Skip to main content

Day: February 6, 2025

XPO Reports Fourth Quarter and Full Year 2024 Results

GREENWICH, Conn., Feb. 06, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) today announced its financial results for the fourth quarter 2024. The company reported diluted earnings from continuing operations per share of $0.63, compared with $0.49 for the same period in 2023, and adjusted diluted earnings from continuing operations per share of $0.89, compared with $0.77 for the same period in 2023. For the full year 2024, the company reported diluted earnings from continuing operations per share of $3.23, compared with $1.62 for 2023, and adjusted diluted earnings from continuing operations per share of $3.83, compared with $2.92 for 2023.Fourth Quarter and Full Year 2024 Results                                                                     Three Months Ended December 31,   Years Ended December 31,    Revenue   Operating...

Continue reading

Bombardier Posts Fourth Consecutive Year of Diversified Growth and Solid Financial Performance

Revenues beat guidance and grew year-over-year to $8.7 billion, driven by record service performance exceeding $2.0 billion, and 146 aircraft deliveries. Adjusted EBITDA(1) up 11% year-over-year to $1.36 billion, and adjusted EBITDA margin(2) reached 15.7%. Full-year reported EBIT reached $878 million. Net income and adjusted net income(1) were $370 million and $547 million respectively. Diluted EPS(3) reached $3.40, while adjusted EPS(2) was up 31% year-over-year, from $3.94 to $5.16. Free cash flow generation(1) of $232 million; reported cash flows from operating activities(3) and net additions to PP&E and intangible assets were at $405 million and $173 million respectively. Backlog(4) up year-over-year to $14.4 billion as at December 31, 2024. Unit book-to-bill(5) of 1.0 demonstrates consistent demand. Solid progress on deleveraging...

Continue reading

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Revenue of $290.3 million in Q3, up 2.7% versus prior year Diluted EPS of $1.22 in Q3 increased approximately 15% versus prior year Reduced leverage to 2.5x in Q3, driven by strong profitability and cash flow Raising full-year fiscal 2025 earnings outlookTARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024. “We are pleased with our strong third quarter results that delivered both record quarterly sales and earnings per share. Sales trends benefitted from continued strong International business performance and was further helped by sequentially improved Clear Eyes® revenues. Continued robust free cash flow enabled us to pay off all remaining variable debt, allowing for further capital...

Continue reading

ZRG Acquires Aspen Leadership Group, Cementing Market Leadership in Education Talent Solutions

ROCHELLE PARK, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) — ZRG, one of the world’s fastest-growing global talent advisory and executive search firms, today announced the acquisition of Aspen Leadership Group (ALG), the premier firm in placing and supporting fundraising and other leaders in education and the broader nonprofit sector. This strategic acquisition reinforces ZRG’s leadership position and ongoing investment in higher education, where synergies between Aspen Leadership Group and ZRG’s expanding, industry-leading portfolio establish the most comprehensive talent solution suite available today. Together the firms bring unmatched expertise across executive search, interim leadership, consulting/coaching, and embedded recruiting. With ALG’s specialized focus in development and advancement, and its complementary expertise in finance...

Continue reading

Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on Thursday, February 20, 2025

Earnings Call Scheduled for 7:00 a.m. ET on February 20, 2025 SHANGHAI, Feb. 06, 2025 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it will report its fourth quarter and fiscal year 2024 unaudited financial results on Thursday, February 20, 2025, before the open of U.S. markets. The Company’s management will host an earnings conference call at 7:00 AM U.S. Eastern Time on February 20, 2025 (8:00 PM Beijing/Hong Kong Time on February 20, 2025). Details for the conference call are as follows:Event Title: Bilibili Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference CallRegistration Link: https://register.vevent.com/register/BI046d59fdf9624b6cb006d78f34c43ca0   All participants...

Continue reading

Vistin Pharma ASA: Invitation to Q4 2024 conference call

Oslo, Norway, 6 February 2025 Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The fourth quarter conference call will be available via web and audio through the following access points: Webcast: https://edge.media-server.com/mmc/p/ekueptdm Telephone conference (online registration): https://register.vevent.com/register/BI6693743078794f05ac2e84522925591f ***** For further information, please contact: Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.comAbout Vistin Pharma | www.vistin.com Vistin Pharma is a Norwegian pharmaceutical company...

Continue reading

Regarding the change of the Manager of closed-end investment company intended for informed investors UAB “Atsinaujinančios energetikos investicijos”

The closed-end investment company UAB “Atsinaujinančios energetikos investicijos” (hereinafter – the Investment Company) informs that from February 7, 2025, the manager of the Investment Company, Grėtė Bukauskaitė, will go on maternity leave. The new manager of the Investment Company has been elected and appointed – Mr. Mantas Auruškevičius, who has been working at the management company UAB “Lords LB Asset Management” since 2021. Contact person for further information: Rūta Abromavičienė, Legal Officer of LORDS LB ASSET MANAGEMENT, UAB ruta.abromaviciene@lordslb.lt 

Continue reading

HighCo: Shareholding as 01/31/2025

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)January 31, 2025 20 455 403 818 981 22 282 977 21 463 996December 31, 2024 20 455 403 817 845 22 282 774 21 464 929(*) exclusively consisting of treasury shares.(**) theoretical voting rights to calculate the threshold crossing including the voting right of treasury shares (article 223-11 of the General Regulations AMF). About HighCo As an expert in marketing and communication, HighCo...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.